Relief Cardiovascular
PrivateLast Round
Series A
Jan 8, 2025
Total Funding Raised
$12M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Relief Cardiovascular operates in Healthcare & Life Sciences and is based in Irvine, California. Its latest recorded funding round was a Series A round in January 2025.
Relief Cardiovascular is a medical device company that is developing the Relief System, a transcatheter smart implant designed to monitor and modulate venous pressure to manage congestion in heart failure patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Clinical Trials
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Relief Cardiovascular Comparables
Compare Relief Cardiovascular with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adona Medical | 79% | |
| Johnson & Johnson | 73% | |
| Alleviant Medical | 73% |
For institutional investors. Book with your work email.
Relief Cardiovascular Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Relief Cardiovascular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Good Growth Capital | Series A |
| Advent Life Sciences | Series A |
| Broadview Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 36% MoM.
- Jul 21, 2026
Grew 29% QoQ, from 14 to 18 employees.
For institutional investors. Book with your work email.
Relief Cardiovascular Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Relief Cardiovascular's valuation, stock price, and market status.
Is Relief Cardiovascular a public or private company?
Relief Cardiovascular is a private company.
What is the current stock price of Relief Cardiovascular?
Relief Cardiovascular is a private company, so its shares have no public market price. Caplight tracks Relief Cardiovascular's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Relief Cardiovascular worth (valuation)?
Valuation information for Relief Cardiovascular is not publicly available.
Can I buy Relief Cardiovascular stock?
Relief Cardiovascular shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Relief Cardiovascular's last funding round?
Relief Cardiovascular's most recent funding round was Series A on January 8, 2025.
Who are the main investors in Relief Cardiovascular?
Key investors in Relief Cardiovascular include Advent Life Sciences, Broadview Ventures.
Will Relief Cardiovascular IPO soon?
No public IPO plans have been announced for Relief Cardiovascular.
How can I track Relief Cardiovascular secondary market activity?
Caplight tracks bids, offers, and trades in Relief Cardiovascular's shares on secondary markets.